Alembic's Generic Doxercalciferol Receives Approval in the U.S.
Eugia Pharma's Generic Doxercalciferol Receives Approval in the U.S.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the therapeutic generic equivalent of Hectorol® (doxercalciferol) Injection 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, approved by the U.S. Food and Drug Administration (USFDA).
Gland Pharma`s Generic Doxercalciferol Receives Approval in US
Lupin has garnered the Food and Drug Administration’s clearance for doxercalciferol injection,in 4 mcg/2 mL (2 mcg/mL) multi-dose vials.
Lupin`s Generic Doxercalciferol Receives Approval in US
Enforcement Report - Week of April 19, 2017
Rising Pharms Generic Doxercalciferol Approved In US
Akorn`s Generic Doxercalciferol Approved in US For Hyperparathyroidism and Bone Disease